372 related articles for article (PubMed ID: 26082451)
41. Solitary skin lesions with histopathologic features of early mycosis fungoides.
Cerroni L; Fink-Puches R; El-Shabrawi-Caelen L; Soyer HP; LeBoit PE; Kerl H
Am J Dermatopathol; 1999 Dec; 21(6):518-24. PubMed ID: 10608243
[TBL] [Abstract][Full Text] [Related]
42. Granulomatous syringotropic mycosis fungoides with two lesions having reactive B-cell proliferation.
Wang L; Wang G; Gao T
J Cutan Pathol; 2014 Apr; 41(4):400-6. PubMed ID: 24438472
[TBL] [Abstract][Full Text] [Related]
43. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.
Nielsen M; Kaltoft K; Nordahl M; Röpke C; Geisler C; Mustelin T; Dobson P; Svejgaard A; Odum N
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6764-9. PubMed ID: 9192639
[TBL] [Abstract][Full Text] [Related]
44. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
45. More or less: copy number alterations in mycosis fungoides.
Lin WM; Girardi M
J Invest Dermatol; 2010 Apr; 130(4):926-8. PubMed ID: 20231832
[TBL] [Abstract][Full Text] [Related]
46. Clinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides.
Horwitz SM; Duvic M; Hsi ED
Clin Adv Hematol Oncol; 2010 Dec; 8(12):1-15. PubMed ID: 21344783
[TBL] [Abstract][Full Text] [Related]
47. miRNA in mycosis fungoides and skin inflammation.
Persson JL
APMIS; 2013 Nov; 121(11):1017-9. PubMed ID: 24106870
[TBL] [Abstract][Full Text] [Related]
48. Solitary mycosis fungoides: a distinct clinicopathologic entity with a good prognosis: a series of 15 cases and literature review.
Ally MS; Pawade J; Tanaka M; Morris S; Mitchell T; Child F; Wain M; Whittaker S; Robson A
J Am Acad Dermatol; 2012 Oct; 67(4):736-44. PubMed ID: 22533993
[TBL] [Abstract][Full Text] [Related]
49. Myocosis fungoides--an update on a non-mycotic disease.
Makdisi J; Friedman A
J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
[TBL] [Abstract][Full Text] [Related]
50. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
[TBL] [Abstract][Full Text] [Related]
51. Array-based comparative genomic hybridization in early-stage mycosis fungoides: recurrent deletion of tumor suppressor genes BCL7A, SMAC/DIABLO, and RHOF.
Carbone A; Bernardini L; Valenzano F; Bottillo I; De Simone C; Capizzi R; Capalbo A; Romano F; Novelli A; Dallapiccola B; Amerio P
Genes Chromosomes Cancer; 2008 Dec; 47(12):1067-75. PubMed ID: 18663754
[TBL] [Abstract][Full Text] [Related]
52. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
[TBL] [Abstract][Full Text] [Related]
53. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
54. CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients.
Fierro MT; Novelli M; Savoia P; Cambieri I; Quaglino P; Osella-Abate S; Bernengo MG
J Cutan Pathol; 2001 Aug; 28(7):356-62. PubMed ID: 11437941
[TBL] [Abstract][Full Text] [Related]
55. Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model.
Tun-Kyi A; Qin JZ; Oberholzer PA; Navarini AA; Hassel JC; Dummer R; Döbbeling U
Ann Oncol; 2008 Aug; 19(8):1488-1494. PubMed ID: 18349030
[TBL] [Abstract][Full Text] [Related]
56. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
[TBL] [Abstract][Full Text] [Related]
57. Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage-A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis.
Lai J; Li J; Gniadecki R; Lai R
Cells; 2021 Nov; 10(11):. PubMed ID: 34831413
[TBL] [Abstract][Full Text] [Related]
58. A new molecular paradigm in mycosis fungoides and Sézary syndrome.
Elenitoba-Johnson KS; Wilcox R
Semin Diagn Pathol; 2017 Jan; 34(1):15-21. PubMed ID: 28024703
[TBL] [Abstract][Full Text] [Related]
59. Childhood mycosis fungoides: experience of 28 patients and response to phototherapy.
Laws PM; Shear NH; Pope E
Pediatr Dermatol; 2014; 31(4):459-64. PubMed ID: 24916067
[TBL] [Abstract][Full Text] [Related]
60. The different faces of mycosis fungoides: results of a single-center study.
Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
